Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02249104 · ClinicalTrials.gov registry record · Phase 4
A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT02249104 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 28 participants.
The verdict
NCT02249104, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate a complete topical acne regimen consisting of a prescription acne medication (Epiduo® Gel) and an acne-specific cleanser (Cetaphil® DermaControl™ Foam Wash) and moisturizer with sunscreen (Cetaphil® DermaControl™ Moisturizer SPF 30) for safety, efficacy and patient satisfaction in student athletes with acne vulgaris.
Interventions
- DRUG Adapalene/benzoyl peroxide gel, 0.1%/2.5%
- OTHER Cetaphil Acne Regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02249104
The ClinicalTrials.gov registry entry for NCT02249104 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adapalene/benzoyl peroxide gel, 0.1%/2.5% is the first listed.
NCT02249104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02249104 about?
NCT02249104 is a clinical study titled "A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris". The goal of this study is to evaluate a complete topical acne regimen consisting of a prescription acne medication (Epiduo® Gel) and an acne-specific cleanser (Cetaphil® DermaControl™ Foam Wash) and moisturizer with sunscreen (Cetaphil® DermaControl™ Moisturizer SPF 30) for safety, efficacy and pati...
What is the current status of trial NCT02249104?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2014-08. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02249104?
The interventions under investigation include: Adapalene/benzoyl peroxide gel, 0.1%/2.5% (DRUG), Cetaphil Acne Regimen (OTHER).
Who is sponsoring clinical trial NCT02249104?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.